| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |